GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SSY Group Ltd (HKSE:02005) » Definitions » Gross Margin %

SSY Group (HKSE:02005) Gross Margin % : 53.51% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is SSY Group Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. SSY Group's Gross Profit for the six months ended in Dec. 2023 was HK$1,675 Mil. SSY Group's Revenue for the six months ended in Dec. 2023 was HK$3,130 Mil. Therefore, SSY Group's Gross Margin % for the quarter that ended in Dec. 2023 was 53.51%.

Warning Sign:

SSY Group Ltd gross margin has been in long-term decline. The average rate of decline per year is -2.7%.


The historical rank and industry rank for SSY Group's Gross Margin % or its related term are showing as below:

HKSE:02005' s Gross Margin % Range Over the Past 10 Years
Min: 47.24   Med: 57.38   Max: 63.56
Current: 56.01


During the past 13 years, the highest Gross Margin % of SSY Group was 63.56%. The lowest was 47.24%. And the median was 57.38%.

HKSE:02005's Gross Margin % is ranked better than
66.26% of 990 companies
in the Drug Manufacturers industry
Industry Median: 46.705 vs HKSE:02005: 56.01

SSY Group had a gross margin of 53.51% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for SSY Group was -2.70% per year.


SSY Group Gross Margin % Historical Data

The historical data trend for SSY Group's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SSY Group Gross Margin % Chart

SSY Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 62.06 63.56 59.18 55.45 56.01

SSY Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.36 56.97 53.74 58.35 53.51

Competitive Comparison of SSY Group's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, SSY Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SSY Group's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SSY Group's Gross Margin % distribution charts can be found below:

* The bar in red indicates where SSY Group's Gross Margin % falls into.



SSY Group Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

SSY Group's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=3619.6 / 6463.009
=(Revenue - Cost of Goods Sold) / Revenue
=(6463.009 - 2843.37) / 6463.009
=56.01 %

SSY Group's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=1674.9 / 3129.852
=(Revenue - Cost of Goods Sold) / Revenue
=(3129.852 - 1454.964) / 3129.852
=53.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


SSY Group  (HKSE:02005) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

SSY Group had a gross margin of 53.51% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


SSY Group Gross Margin % Related Terms

Thank you for viewing the detailed overview of SSY Group's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


SSY Group (HKSE:02005) Business Description

Traded in Other Exchanges
N/A
Address
Central Plaza, 18 Harbour Road, Rooms 4902-03, 49th Floor, Wanchai, Hong Kong, HKG
SSY Group Ltd is engaged in the research, development, manufacturing and selling of a wide range of pharmaceutical products, which includes finished medicines of mainly intravenous infusion solution and ampoule injection to hospitals and distributors, bulk pharmaceuticals and medical materials. The company has two reportable segments including intravenous infusion solution and others and medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials.

SSY Group (HKSE:02005) Headlines

No Headlines